Laboratory analysis
Ended Purchase Order Awarded Last action
- Contract number
- 75N91025P00244
- Awardee
-
Eurofins Pharma Bioanalytics Services US, LLC UEI JL23CDPHLER3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $12,075
Award facts
- Contract value 100% obligated
- $12,075.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- St Peters, MO 63304, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute (NCI), a civilian federal agency, awarded a $12,075.00 firm fixed price purchase order contract to Eurofins Pharma Bioanalytics Services US, LLC, a foreign-owned for-profit organization, for laboratory analysis services. The contract has a period of performance ending on March 19, 2026 and was awarded on March 20, 2025. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91025P00244?
75N91025P00244 was awarded to Eurofins Pharma Bioanalytics Services US, LLC by National Cancer Institute (National Institutes of Health) on March 20, 2025.
How much is contract 75N91025P00244 worth?
The government has obligated $12,075 on 75N91025P00244.
Was contract 75N91025P00244 competed?
The extent of competition for 75N91025P00244 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award